NextBio is a biotechnology startup founded in 2004, headquartered in the United States. The company offers an innovative platform for life science researchers, enabling them to unlock knowledge within public and proprietary data. Their seamless SaaS solution has garnered support from investors, including Signatures Capital and Newbury Ventures, who made an $8.00M Series C investment on 18 September 2009. NextBio's platform combines powerful tools with unique correlated content, transforming information into knowledge and laying the foundation for new scientific discoveries. It aims to assist organizations in increasing productivity and improving collaboration across therapeutic groups and geographic boundaries in the fields of biotechnology, enterprise software, and healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | $8.00M | 2 |
|
18 Sep 2009 |
| Series B | $7.00M | 2 |
|
06 Jun 2007 |
| Series A | $1.10M | 1 |
|
01 Jan 2005 |
No recent news or press coverage available for NextBio.
We care about your data, and we'd love to use cookies make your experience better.
